Back to Journals » OncoTargets and Therapy » Volume 7

FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping

Total article views   HTML views PDF downloads Totals
11,096 Dovepress* 9,764+ 1,289 11,053
PubMed Central* 1,332 499 1,831
Totals 11,096 1,788 12,884
*Since 21 November 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on PubMed Central and Google Scholar